Projects In Knowledge

The Disclosure Policy of Projects In Knowledge requires that faculty participating in a CME activity disclose to the audience any significant relationship they may have with a pharmaceutical or medical equipment company, product, or service that may be mentioned as part of their presentation, as well as any relationship with the commercial supporter of this activity.

This independent CME activity is supported by an unrestricted educational grant from Schering Oncology/Biotech.

This activity may include a discussion of therapies that are unapproved for use or investigational, ongoing research, or preliminary data.

The opinions expressed during this activity are those of the faculty and do not necessarily reflect those of the sponsor or the commercial supporter.

Steven I. Cohen, MD, has received grant/research support from Merck & Co, Inc; is a consultant for Schering Corporation; is a member of the speakers bureau of Merck & Co, Inc, Pfizer Inc, and Schering Corporation; and is a stock shareholder in Merck & Co, Inc, Pfizer Inc, and Schering Corporation.

Leonard G. Gomella, MD, is a consultant for and is a member of the speakers bureau of Schering Oncology Biotech.

Donald L. Lamm, MD, has received grant/research support from Schering; and is a member of the speakers bureau of Aventis Pharmaceuticals, Organon Inc, and Schering.

Michael A. O'Donnell, MD, has received grant/research support from Eli Lilly and Company, and Schering-Plough Corporation; and is a stock shareholder in MycImmune.